Instil Bio, Inc.
NASDAQ:TIL
31.5 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0.138 | 0 |
| Cost of Revenue
| 3.61 | 4.756 | 5.987 | 2.752 | 0 | 0.02 |
| Gross Profit
| -3.61 | -4.756 | -5.987 | -2.752 | 0.138 | -0.02 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 1 | 0 |
| Reseach & Development Expenses
| 10 | 42.988 | 141.056 | 107.251 | 19.399 | 4.027 |
| General & Administrative Expenses
| 44.21 | 47.553 | 62.235 | 48.309 | 14.383 | 2.558 |
| Selling & Marketing Expenses
| 0 | -4.756 | 0 | 0 | 0 | 0 |
| SG&A
| 44.21 | 42.797 | 62.235 | 48.309 | 14.383 | 2.558 |
| Other Expenses
| 19.331 | 0 | -3.108 | 0 | 0 | 0 |
| Operating Expenses
| 73.541 | 85.785 | 200.183 | 155.56 | 33.782 | 6.585 |
| Operating Income
| -73.541 | -90.541 | -206.17 | -155.56 | -33.644 | -6.585 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -243.797 | 0 |
| Total Other Income Expenses Net
| -0.594 | -65.546 | -19.08 | -1.195 | -3.943 | 0.063 |
| Income Before Tax
| -74.135 | -156.087 | -225.25 | -156.755 | -37.587 | -6.522 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -272.37 | 0 |
| Income Tax Expense
| 0 | 0 | -2.073 | 0.039 | 0.151 | 0 |
| Net Income
| -74.135 | -156.087 | -223.177 | -156.794 | -37.738 | -6.454 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -273.464 | 0 |
| EPS
| -11.39 | -24 | -34.46 | -29.6 | -5.89 | -1.01 |
| EPS Diluted
| -11.39 | -24 | -34.46 | -29.6 | -5.89 | -1.01 |
| EBITDA
| -61.533 | -146.122 | -217.38 | -154.003 | -33.388 | -6.502 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -241.942 | 0 |